Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+28.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+28.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 71.08% |
| 2024 | -56.54% |
| 2023 | -105.46% |
| 2022 | 33.42% |
| 2021 | 10.14% |
| 2020 | -12.77% |
| 2019 | -50.63% |
| 2018 | -306.90% |
| 2017 | -184.48% |
| 2016 | 0.00% |